Graphico

Graphico CROIC

Delisted

The Cash Return on Invested Capital (CROIC) of Graphico (4930.T) as of Nov 14, 2026 is 14.90 %. In the previous year, Cash Return on Invested Capital (CROIC) was -24.74 % — a change of -160.22% (higher).

CROIC

14.90 %

YoY

-160.22%

Last updated:

Cash Return on Invested Capital (CROIC) of Graphico is 2023 14.90 % . Cash Return on Invested Capital (CROIC) of Graphico was 2022 -24.74 % . It decreases by -160.22% higher compared to the previous year.

The Graphico CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2014
11.06 JPY
Jan 1, 2015
7.39 JPY
Jan 1, 2018
-41.74 JPY
Jan 1, 2019
19.42 JPY
Jan 1, 2020
13.30 JPY
Jan 1, 2021
-8.72 JPY
Jan 1, 2022
-24.74 JPY
Jan 1, 2023
14.90 JPY
The Graphico CROIC history
YEARCROICYoY
14.90 %-160.22%
-24.74 %+183.89%
-8.72 %-165.54%
13.30 %-31.53%
19.42 %-146.53%
-41.74 %-665.23%
7.39 %-33.20%
11.06 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Graphico Stock analysis

What does Graphico do? Graphico Inc. generates revenue through the sale of health foods, cosmetics, ethical drugs, over-the-counter drugs, and household products via drug stores, general merchandise stores, home centers, variety stores, and mail-order channels. The company outsources manufacturing and logistics while focusing on product planning, development, marketing, and sales. Its main product categories include healthcare centered on health foods, beauty care centered on cosmetics, and ethical and over-the-counter drugs. Overseas sales are handled through country-specific distributors. The company targets consumers seeking health and beauty solutions through established retail channels and direct mail-order services. Product planning and development are central to its strategy, with a focus on health foods, cosmetics, and pharmaceuticals. The firm operates as a fabless business model, relying on external partners for manufacturing and logistics to maintain agility in product innovation. Graphico Inc. serves multiple segments including health-conscious women, beauty care consumers, and individuals seeking over-the-counter medications. Sales channels include drug stores, GMS, home centers, variety stores, and mail-order systems. The company's overseas presence is supported by distributors in each country, enabling global market access without direct operational infrastructure. Graphico is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Graphico stock

Cash Return on Invested Capital (CROIC) of Graphico is 14.90 % in 2023.

Cash Return on Invested Capital (CROIC) of Graphico changed from -24.74 % to 14.90 %, representing a -160.22% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) Graphico since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s Graphico with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Graphico

All Key Metrics — Graphico